Shengyu Cui

528 total citations
31 papers, 407 citations indexed

About

Shengyu Cui is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shengyu Cui has authored 31 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Cancer Research and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shengyu Cui's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). Shengyu Cui is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). Shengyu Cui collaborates with scholars based in China and Japan. Shengyu Cui's co-authors include Xinhui Zhu, Jianbo Fan, Hong Yi, Zhiming Cui, Jianning Zhao, Bo Tao, Zhiming Cui, Dawei Xu, Wei Zhang and Wei Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Shengyu Cui

31 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengyu Cui China 13 261 126 49 44 39 31 407
Linjie He China 7 223 0.9× 98 0.8× 29 0.6× 31 0.7× 24 0.6× 12 341
Soo Hyuk Kim South Korea 11 171 0.7× 92 0.7× 84 1.7× 74 1.7× 50 1.3× 14 388
Liu Ouyang China 12 239 0.9× 118 0.9× 35 0.7× 46 1.0× 35 0.9× 25 393
Chenxi Xiao China 14 322 1.2× 77 0.6× 26 0.5× 97 2.2× 41 1.1× 31 562
Zhongwen Qi China 13 330 1.3× 107 0.8× 116 2.4× 64 1.5× 64 1.6× 18 500
Xiaochun Lin China 12 201 0.8× 104 0.8× 28 0.6× 39 0.9× 36 0.9× 35 406
Qinfeng Li China 8 329 1.3× 139 1.1× 131 2.7× 37 0.8× 47 1.2× 13 481
Yandong Bao China 10 235 0.9× 153 1.2× 46 0.9× 43 1.0× 26 0.7× 12 355
Jin‐Yan Shang China 10 254 1.0× 115 0.9× 34 0.7× 65 1.5× 43 1.1× 12 440

Countries citing papers authored by Shengyu Cui

Since Specialization
Citations

This map shows the geographic impact of Shengyu Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyu Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyu Cui more than expected).

Fields of papers citing papers by Shengyu Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyu Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyu Cui. The network helps show where Shengyu Cui may publish in the future.

Co-authorship network of co-authors of Shengyu Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Shengyu Cui. A scholar is included among the top collaborators of Shengyu Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengyu Cui. Shengyu Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Zixuan, et al.. (2024). AMPA receptor inhibition alleviates inflammatory response and myocardial apoptosis after myocardial infarction by inhibiting TLR4/NF-κB signaling pathway. International Immunopharmacology. 133. 112080–112080. 2 indexed citations
3.
Yuan, Kun, et al.. (2023). Neuroligin-3 activates Akt-dependent Nrf2 cascade to protect osteoblasts from oxidative stress. Free Radical Biology and Medicine. 208. 807–819. 15 indexed citations
4.
Cui, Shengyu, Haoliang Wu, Qinglin He, et al.. (2023). Fucoxanthin alleviated atherosclerosis by regulating PI3K/AKT and TLR4/NFκB mediated pyroptosis in endothelial cells. International Immunopharmacology. 120. 110370–110370. 16 indexed citations
5.
Zhang, Xutao, Shengyu Cui, Yuewen Ding, et al.. (2023). Downregulation of B4GALT5 attenuates cardiac fibrosis through Lumican and Akt/GSK-3β/β-catenin pathway. European Journal of Pharmacology. 963. 176263–176263. 2 indexed citations
6.
Cui, Shengyu, Xutao Zhang, Yuhua Li, et al.. (2023). UGCG modulates heart hypertrophy through B4GalT5-mediated mitochondrial oxidative stress and the ERK signaling pathway. Cellular & Molecular Biology Letters. 28(1). 71–71. 8 indexed citations
7.
Li, Shuang, et al.. (2023). Curcumol alleviates cardiac remodeling via the AKT/NF-κB pathway. International Immunopharmacology. 122. 110527–110527. 11 indexed citations
8.
Wu, Haoliang, et al.. (2023). Comprehensive Optimization of Western Blotting. Gels. 9(8). 652–652. 1 indexed citations
9.
Cui, Shengyu, et al.. (2022). Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation. SHILAP Revista de lepidopterología. 7 indexed citations
10.
Li, Yuhua, et al.. (2022). FGF5 alleviated acute lung injury via AKT signal pathway in endothelial cells. Biochemical and Biophysical Research Communications. 634. 152–158. 4 indexed citations
11.
Cui, Shengyu, et al.. (2021). Knockdown of long non-coding RNA LEF1-AS1 attenuates apoptosis and inflammatory injury of microglia cells following spinal cord injury. Journal of Orthopaedic Surgery and Research. 16(1). 6–6. 15 indexed citations
12.
Yi, Hong, Wei Zhang, Shengyu Cui, et al.. (2021). Identification and validation of key long non-coding RNAs in resveratrol protect against IL-1β-treated chondrocytes via integrated bioinformatic analysis. Journal of Orthopaedic Surgery and Research. 16(1). 421–421. 8 indexed citations
13.
Cui, Shengyu, Bo Tao, Yong Pu, et al.. (2020). miR‐145 attenuates cardiac fibrosis through the AKT/GSK‐3β/β‐catenin signaling pathway by directly targeting SOX9 in fibroblasts. Journal of Cellular Biochemistry. 122(2). 209–221. 35 indexed citations
14.
Zhang, Wei, et al.. (2020). MiR-708 inhibits MC3T3-E1 cells against H2O2-induced apoptosis through targeting PTEN. Journal of Orthopaedic Surgery and Research. 15(1). 255–255. 19 indexed citations
15.
16.
Yi, Hong, Wei Zhang, Zhiming Cui, et al.. (2020). Resveratrol alleviates the interleukin-1β-induced chondrocytes injury through the NF-κB signaling pathway. Journal of Orthopaedic Surgery and Research. 15(1). 424–424. 39 indexed citations
17.
Fan, Jianbo, Wei Liu, Xinhui Zhu, et al.. (2019). microRNA-7 inhibition protects human osteoblasts from dexamethasone via activation of epidermal growth factor receptor signaling. Molecular and Cellular Biochemistry. 460(1-2). 113–121. 22 indexed citations
18.
Xu, Dawei, Wei Zhao, Xinhui Zhu, et al.. (2016). OSU53 Rescues Human OB-6 Osteoblastic Cells from Dexamethasone through Activating AMPK Signaling. PLoS ONE. 11(9). e0162694–e0162694. 7 indexed citations
19.
Zhu, Xinhui, Xiaolong Deng, Hong Yi, et al.. (2014). C6 ceramide sensitizes pemetrexed-induced apoptosis and cytotoxicity in osteosarcoma cells. Biochemical and Biophysical Research Communications. 452(1). 72–78. 11 indexed citations
20.
Xu, Dawei, Shengyu Cui, Yuyu Sun, et al.. (2011). Overexpression of glucose-regulated protein 94 after spinal cord injury in rats. Journal of the Neurological Sciences. 309(1-2). 141–147. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linjie He Breakdown of academic impact, for papers by Soo Hyuk Kim Breakdown of academic impact, for papers by Liu Ouyang Breakdown of academic impact, for papers by Chenxi Xiao Breakdown of academic impact, for papers by Zhongwen Qi Breakdown of academic impact, for papers by Xiaochun Lin Breakdown of academic impact, for papers by Qinfeng Li Breakdown of academic impact, for papers by Yandong Bao Breakdown of academic impact, for papers by Jin‐Yan Shang
Rankless by CCL
2026